Akebia Therapeutics Inc (AKBA)
1.82
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 09:41
Akebia Therapeutics Shareholders Equity (Quarterly): -50.40M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -50.40M |
| June 30, 2024 | -33.75M |
| March 31, 2024 | -27.26M |
| December 31, 2023 | -30.58M |
| September 30, 2023 | -39.42M |
| June 30, 2023 | -26.81M |
| March 31, 2023 | -14.35M |
| December 31, 2022 | 5.23M |
| September 30, 2022 | 13.85M |
| June 30, 2022 | 62.30M |
| March 31, 2022 | 26.12M |
| December 31, 2021 | 74.01M |
| September 30, 2021 | 137.15M |
| June 30, 2021 | 174.63M |
| March 31, 2021 | 213.89M |
| December 31, 2020 | 247.62M |
| September 30, 2020 | 317.96M |
| June 30, 2020 | 370.26M |
| March 31, 2020 | 396.36M |
| December 31, 2019 | 394.76M |
| September 30, 2019 | 467.56M |
| June 30, 2019 | 519.36M |
| Date | Value |
|---|---|
| March 31, 2019 | 566.38M |
| December 31, 2018 | 635.93M |
| September 30, 2018 | 142.54M |
| June 30, 2018 | 165.92M |
| March 31, 2018 | 197.10M |
| December 31, 2017 | 122.57M |
| September 30, 2017 | 99.88M |
| June 30, 2017 | 57.00M |
| March 31, 2017 | 30.62M |
| December 31, 2016 | 68.12M |
| September 30, 2016 | 100.71M |
| June 30, 2016 | 133.29M |
| March 31, 2016 | 167.76M |
| December 31, 2015 | 131.00M |
| September 30, 2015 | 145.41M |
| June 30, 2015 | 149.75M |
| March 31, 2015 | 94.61M |
| December 31, 2014 | 104.08M |
| September 30, 2014 | 113.61M |
| June 30, 2014 | 121.55M |
| March 31, 2014 | 127.87M |
| December 31, 2013 | 30.76M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-50.40M
Minimum
Sep 2024
396.36M
Maximum
Mar 2020
110.58M
Average
44.21M
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 638.84M |
| Eli Lilly and Co | 14.24B |
| Bioventus Inc | 148.74M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 207.14M |
| Total Liabilities (Quarterly) | 257.54M |
| Debt to Equity Ratio | -0.761 |
| Current Ratio | 1.524 |
| Net Debt Paydown Yield | 0.30% |